F012 Treating the "Outsides" of the Inpatient: Pediatric Consults for the General Dermatologist
DESCRIPTION
This session is designed with general and resident dermatologists in mind, but will also be of interest to pediatric dermatology fellows and attending physicians. We aim to present a variety of challenging cases which will illustrate management of acute and severe pediatric skin disease. We will demonstrate the role of the dermatologist in diagnosing and managing these conditions as a member of a multidisciplinary care team. Areas of focus will include the following: severe medication reactions and other inflammatory conditions, infections, the immunocompromised pediatric patient and the newborn.
LEARNING OBJECTIVES
Evaluate cutaneous findings in children with immunosuppression or malignancy.
Diagnose skin findings in newborns suggestive of life-threatening systemic disease.
Identify and manage severe medication reactions and other life-threatening infectious and inflammatory disorders in children.
DIRECTOR
Cheryl Marie Bayart, MD, FAAD
SPEAKERS
Colleen Cotton, MD, FAAD
Kaiane Habeshian, MD, FAAD
Elena B. Hawryluk, MD, PhD, FAAD
Kalyani Marathe, MD, MPH, FAAD
Vikash Sudhir Oza, MD, FAAD
HANDOUTS
DISCLOSURES
Cheryl Marie Bayart, MD, FAAD
No financial relationships exist with ineligible companies.
Colleen Cotton, MD, FAAD
Amgen – Investigator(Grants/Research Funding); CorEvitas – Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); HS Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Inner Archways LLC – Advisory Board(Other Financial Benefit); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);
Kaiane Habeshian, MD, FAAD
No financial relationships exist with ineligible companies.
Elena B. Hawryluk, MD, PhD, FAAD
Apogee Therapeutics – Advisory Board(Honoraria); UpToDate, Inc – Other(Other Financial Benefit);
Kalyani Marathe, MD, MPH, FAAD
Guidepoint Global, LLC – Advisory Board(Fees); Leo Pharma – Advisory Board(Honoraria);
Vikash Sudhir Oza, MD, FAAD
Apogee BioPharm – Consultant(Honoraria); Eli Lilly – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Incyte – Advisory Board(Honoraria); National Eczema Association – Advisory Board(Honoraria); Pelthos Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);